Improve the quality of your HTA submissions with our expert insight into dynamic payer thinking
We appreciate that one of the key challenges in developing an appropriate market access strategy is keeping up-to-date with the rapidly advancing treatment landscape and dynamic payer thinking. A deep understanding of pricing and reimbursement decisions, how payers have attempted to dilute value, and how these perspectives are evolving is critical to making the right investment decisions.
Updates at your fingertips on just published regulatory, reimbursement/HTA, and pricing decisions, augmented by in-depth analysis of the submitted evidence and payer feedback
Easily digestible price and HTA decision information on dashboards and interactive graphs, across comparator products and HTA agencies
Facilitates early optimization of trial design and key evidence generation activities
Enables your evidence base to be strengthened in line with the evolving HTA landscape
Promotes accelerated cross-team collaboration and alignment in the development of effective HTA strategies
Enhances your decision-making with our critical analysis, interpretation, and recommendations in regular discussion with your team
Leading pharma launches new immunotherapy using insight from the PRMA Tracker®
To support the successful launch of a new immunotherapy for a fast-evolving indication, this noted pharmaceutical company required an in-depth understanding of the latest payer thinking across rapidly advancing global markets. Find out how they approached the challenge.
The regular strategic updates on P&R and HTA decisions are an absolute asset.
The team are impressed with the insight and recommendations specific to our key challenges.
Request a demonstration
Our user friendly applications and expert team have supported organizations around the world in achieving their goals. We are always happy to have an informal, confidential chat and help you re-think your market access challenges.